PTC Therapeutics <PTCT.O>: Morgan Stanley raises target price to $104.00 from $93.00
PTCT•Related News
Fed's Kashkari: Would prefer small rate hikes now rather than waiting
TLT•
Oppenheimer Holdings Q2 EPS USD 2.38
OPY•
J-Star regains Nasdaq compliance with $1 minimum bid price rule
YMAT•
AbbVie Inc outlook FY adjusted EPS USD 13.87 - 14.07
ABBV•
Rtx's Pratt & Whitney Awarded $1.3 Billion F135 Sustainment Contract
RTX•